Yael WeissVice President, Business Development at Ultrageynx
Yael Weiss is Vice President of Business Development at Ultragenyx, a company specializing in the development of therapies for the treatment of rare genetic diseases. Prior to joining Ultragenyx, she spent 10 years at Merck, ultimately heading the group that evaluates the clinical, regulatory and safety aspects of Merck’s regional deals globally. Her earlier roles at Merck included Director of External Scientific Affairs and World Wide Licensing, West Coast and Medical Director at Merck Israel, a role in which she oversaw the company’s clinical trials and supported the sales and marketing organizations. Before joining Merck, Yael served as Director of Medical Affairs and Business Development at Genzyme Israel, and spent several years at Columbine Ventures. Yael began her career practicing medicine at Sheba Medical Center. Yael received her MD degree from Hadassah Medical School in Jerusalem, and her PhD in molecular genetics from the Weizmann Institute of Science in Rehovot, Israel.